Stock AnalizAlbemarle (ALB) earnings for the quarter ended September 2026: EPS beats estimates
Albemarle reported results for the quarter ended September 2026 on November 4, 2026. Adjusted earnings per share came in at $2.58 against the analysts’ average forecast of $2.53, a beat of 2.0%.
Revenue for the quarter was $1.74 billion.
The market’s verdict: the stock rose 9.1% on the first trading day after the report.
The last four quarters
Albemarle has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $2.58 | $2.53 | +2.0% | — | +9.1% |
| Jun 2026 | $3.75 | $3.24 | +15.7% | +31% | +3.8% |
| Mar 2026 | $2.95 | $1.31 | +124.6% | +33% | +1.8% |
| Dec 2025 | -$0.53 | -$0.49 | −8.6% | +16% | −5.7% |
What comes next
Analysts expect EPS of $1.27 for the next quarter on average and $10.51 for the fiscal year ending December 31, 2026.
The average analyst price target is $139.35, 49% above the current price of $93.53.
Valuation and score
Albemarle scores 2.2 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 22.5, and its intrinsic value under moderate assumptions is about 62% below the current market value. Full Albemarle analysis with 10 years of financials
Frequently asked questions
What was Albemarle’s EPS for the quarter ended September 2026?
$2.58 adjusted per share, against an analyst consensus of $2.53.
How much revenue did Albemarle report?
$1.74 billion.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.